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Abstract
Background: Previous studies on factors predicting the prognosis of infective endocarditis have
given somewhat conflicting results. Our aim was to define the factors predicting the outcome of
patients treated in a Finnish teaching hospital.
Methods: A total of 326 episodes of infective endocarditis in 303 patients treated during 1980–
2004 were evaluated for short-term and 1-year outcome and complications.
Results: Infection of 2 native valves and the occurrence of neurological complications, peripheral
emboli, or heart failure significantly predicted both in-hospital and 1-year mortality, while age ≥65
years or the presence of a major criterion or vegetation on echocardiography predicted death
within 1 year. A significant trend was observed between the level of serum C-reactive protein
(CRP) on admission and both the short-term and 1-year outcome. In the patients who had CRP
values ≥100 mg/l on admission, the hazard ratio for in-hospital death was 2.9-fold and the hazard
ratio for 1-year death was 3.9-fold as compared to those with lower CRP values. Male sex and age
< 64 years significantly predicted a need for both in-hospital and 1-year surgery, as did the
development of heart failure or the presence of a major criterion or vegetation on
echocardiography. Peripheral emboli were associated with a need for in-hospital surgery, while
Streptococcus pneumoniae as the causative agent or infection of 2 native valves predicted a need for
surgery within 1 year from admission.
Conclusion: Some of the factors (e.g. heart failure, neurological complications, peripheral emboli)
predicting a poor prognosis and/or need for surgery were the same observed in previous studies.
A new finding was that high CRP values (≥100 mg/l) on admission significantly predicted both short-
term and 1-year mortality.
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Background
Infective endocarditis is a diagnostic and therapeutic chal-
lenge to clinicians. Despite major advances in cardiac
imaging technology, antimicrobial treatment and surgical
techniques, the morbidity and mortality associated with
infective endocarditis remains high. Several previous stud-
ies from the 1990's and 2000's show that mortality of
endocarditis is still from 10% to 24% [1-6]. Some authors
report a decreasing trend in mortality, and this has been
attributed either to lower operative mortality [7], or tech-
nically more successful early valve surgery [6]. Previous
studies have attempted to identify various clinical and
microbial factors predicting either short-term or long-
term mortality of infective endocarditis, with somewhat
conflicting results [5,8-12].
Our previous reports on patients treated for infective
endocarditis in our hospital from 1980 onwards have
focused on diagnostic classification, neurological mani-
festations, and the utility of the serum C-reactive protein
(CRP) in assessing the outcome of the disease [13-15]. We
have also published the changes we have seen in the pres-
entation of endocarditis during the past 25 years [16]. In
the present study, we analyse the short-term and 1-year
clinical outcome of these patients in more detail with the
aim to delineate the factors predicting an adverse outcome
in patients treated for endocarditis in a Finnish teaching
hospital.
Methods
The short-term and 1-year outcome of infective endocar-
ditis was analysed in 303 patients with 326 episodes of
the disease treated at the Turku University Hospital,
Turku, Finland, between 1980 and 2004. The hospital is a
1000-bed teaching facility with a cardiothoracic surgical
department, serving as a tertiary referral centre for the
southwestern part of the country, and as a primary care
facility for infectious diseases for a region of about
200.000 inhabitants.
For each patient, data on age, sex, underlying diseases,
causative agents of infective endocarditis, affected valves
and echocardiographic findings, as well as the develop-
ment of complications were collected by us for our previ-
ous study focusing on the changes of the clinical
characteristics of endocarditis during the 25-year period
[16]. For the present study, the mortality and the need for
surgical treatment were recorded in detail for all patients
during a period of 1 year from admission. In addition to
hospital records, dates of possible deaths were obtained
from the National Population Registry, in which all
deaths and causes of deaths of the Finnish residents are
registered. CRP and erythrocyte sedimentation rate (ESR)
values and white blood cell (WBC) counts on admission
were also registered. The data were used to analyse the
association between various patient and disease character-
istics and the development of complications, mode of
treatment and mortality of infective endocarditis. The fac-
tors predicting a poor short-term and 1-year clinical out-
come and the requirement for surgical treatment were also
delineated.
Short-term outcome was defined as the outcome during
the index hospitalisation.
The study was approved by the Institutional Committee
on human research.
Statistical analysis
The associations between the clinical characteristics and
cumulative mortality or cumulative need for surgery was
studied using survival (or event history) analysis. First,
during different time periods the cumulative percentages
for death (table 1) or for need of surgery (table 2) were
estimated using Kaplan-Meyer technique. Differences in
cumulative percentages between groups were tested using
log-rank test. Differences between groups were quantified
by calculating hazard ratios using Cox's regression models
(tables 4 and 5). Associations between in-hospital com-
plications and death or need for surgery were tested using
chi squared test. P-values less than 0.05 were considered
as statistically significant. Statistical computations were
carried out using SAS® release 9.1/2005.
Results
Of the 326 episodes, 224 were designated as definite
infective endocarditis and the rest as possible infective
endocarditis by the Duke criteria [17]. There were 234 epi-
sodes in men and 92 episodes in women. The mean age
(SD) was 54.4 (17.3) years (range 18 to 87 years). Tran-
sthoracic echocardiography (TTE) was performed in all
episodes of IE, followed by transesophageal echocardiog-
raphy (TEE) in 184 episodes. The characteristics of the
patients are presented in tables 1 and 2.
Short-term and 1-year outcome
Patient characteristics
Fifty-three patients died of infective endocarditis during 1
year from admission; 23 of them within 30 days from
admission, and 20 between 1 and 3 months after admis-
sion. The cumulative mortality in various patient groups
is presented in table 1. Mortality was significantly associ-
ated with age (≥65 years) except during the index hospi-
talisation, but not with gender. At all time points,
mortality was significantly higher in Streptococcus pneumo-
niae  endocarditis than in endocarditis caused by other
pathogens or in culture-negative cases (all p values <
0.006), and significantly higher in infections of 2 native
valves than in infections affecting only one native valve or
a prosthetic valve (all p values < 0.001). At 3 months,BMC Infectious Diseases 2007, 7:78 http://www.biomedcentral.com/1471-2334/7/78
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Table 1: Association between cumulative mortality within 1 year and patient characteristics in 326 episodes of infective endocarditis
Mortality during n (%)
NI n - h o s p i t a l a p value 3 months p value 6 months p value 1 year p value
Sex 0.423 0.261 0.328 0.707
Male 234 35 (15.0) 34 (14.7) 38 (16.5) 39 (17.0)
Female 92 11 (12.0) 9 (9.9) 11 (12.1) 14 (15.7)
Age 0.065 0.022 0.013 0.004
18–64 years 209 23 (11.0) 21 (10.2) 24 (11.6) 25 (12.1)
≥65 years 117 23 (19.7) 22 (19.0) 25 (21.8) 28 (24.9)
Etiology 0.031b 0.004b 0.012b 0.036b
Staphylococcus aureus 75 14 (18.7) 14 (18.9) 15 (20.3) 15 (20.3)
CoNSc 31 6 (19.4) 6 (19.4) 6 (19.4) 6 (19.4)
Viridans streptococci 67 10 (14.9) 8 (12.0) 11 (16.8) 12 (18.4)
Enterococcus faecalis 25 2 (8.0) 2 (8.0) 2 (8.0) 3 (12.8)
Streptococcus pneumoniae 11 5 (45.5) 5 (45.5) 5 (45.5) 5 (45.5)
Other 28 2 (7.1) 1 (3.6) 2 (7.3) 2 (7.3)
Negative 89 7 (7.9) 7 (8.1) 8 (9.2) 10.(11.6)
Affected valves <0.001b <0.001b <0.001b <0.001b
Aortic 113 16 (14.2) 15 (13.4) 16 (14.4) 17 (15.4)
Mitral 96 6 (6.3) 7 (7.3) 8 (8.4) 9 (9.5)
Tricuspid 18 2 (11.1) 1 (5.9) 2 (11.8) 2 (11.8)
Two native valves 32 14 (43.8) 13 (40.6) 14 (43.8) 15 (46.9)
Prosthetic valve(s) 67 8 (11.9) 7 (10.6) 9 (13.7) 10 (15.3)
Echocardiography
Major criterion 0.343 0.090 0.028 0.012
Yes 221 37 (16.7) 34 (15.6) 40 (18.4) 44 (20.4)
No 105 9 (8.6) 9 (8.7) 9 (8.7) 9 (8.7)
Vegetation 0.097 0.047 0.010 0.003
Yes 198 36 (18.2) 32 (16.3) 38 (19.5) 42 (21.7)
No 128 10 (7.8) 11 (8.7) 11 (8.7) 11 (8.7)
Neurological eventsd 0.009 0.003 0.003 0.005
Yes 86 21 (24.4) 19 (22.5) 21 (24.9) 22 (26.1)
No 240 25 (10.4) 24 (10.1) 28 (11.8) 31 (13.2)
Peripheral embolid 0.032 0.073 0.016 0.022
Yes 102 22 (22.0) 18 (18.3) 22 (22.6) 23 (23.7)
No 224 24 (10.6) 25 (11.1) 27 (12.1) 30 (13.5)
Heart failured <0.001 <0.001 <0.001 <0.001
Yes 178 41 (23.0) 38 (21.8) 44 (25.5) 47 (27.5)
No 148 5 (3.4) 5 (3.4) 5 (3.4) 6 (4.1)
In-hospital surgery 0.751 0.614 0.551 0.552
Yes 89 15 (16.9) 13 (14.7) 15 (17.0) 16 (18.2)
No 237 31 (13.1) 30 (12.8) 34 (14.6) 37 (16.0)
CRP on admissione 0.005 <0.001 <0.001 <0.001
≥100 mg/l 148 28 (18.9) 29 (19.7) 31 (21.1) 34 (23.3)
< 100 mg/l 124 8 (6.5) 5 (4.1) 8 (6.6) 8 (6.6)
Creatinine on admissionf 0.075 0.017 0.052 0.160
≥100 µmol/l 108 28 (18.9) 19 (17.7) 19 (17.7) 19 (17.7)
< 100 µmol/l 174 17 (9.8) 15 (8.7) 18 (10.4) 22 (12.8)
aMean (SD) duration of in-hospital treatment was 55 (33), range 4 to 272 days; bp values for overall group differences; ccoagulase-negative 
staphylococci; dwithin 3 months from admission; edata available for 272 episodes; fdata available for 282 episodesBMC Infectious Diseases 2007, 7:78 http://www.biomedcentral.com/1471-2334/7/78
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mortality of Staphylococcus aureus endocarditis was signifi-
cantly higher than mortality of endocarditis caused by
other pathogens excluding S. pneumoniae (p = 0.032). At 6
months, the difference still seemed to exist, but did not
reach statistical significance (p = 0.061). Mortality was sig-
nificantly associated with the occurrence of neurological
complications, peripheral emboli (except at 3 months),
and heart failure before 3 months after admission. There
were no statistically significant differences in the outcome
between the patients with different neurological compli-
cations (embolic brain infarction, brain haemorrhage,
transient ischaemic stroke, meningitis) (p values between
0.737 to 0.934). At 6 months and 1 year, mortality was
associated with the presence of a major criterion or a veg-
etation on echocardiography, and at 3 months, also with
the presence of a vegetation. Mortality was not signifi-
Table 2: Cumulative proportion of patients needing surgery within 1 year and clinical characteristics in 326 episodes of infective 
endocarditis
Need for surgery n (%)
N In-hospitala p value 3 months p value 6 months p value 1 year p value
Sex 0.002 0.006 0.010 0.011
Male 234 74 (31.6) 78 (35.0) 83 (37.6) 88 (40.2)
Female 92 15 (16.3) 16 (18.2) 19 (22.1) 21 (24.8)
Age <0.001 <0.001 <0.001 <0.001
18–64 years 209 73 (34.9) 77 (38.1) 84 (41.9) 88 (44.1)
≥65 years 117 16 (13.7) 17 (15.4) 18 (16.5) 21 (20.2)
Etiology 0.584b 0.516b 0.1210b 0.147b
Staphylococcus aureus 75 17 (22.7) 19 (28.6) 19 (28.6) 20 (30.4)
CoNSc 31 9 (29.0) 9 (30.6) 9 (30.6) 9 (30.6)
Viridans streptococci 67 20 (22.9) 20 (31.1) 25 (39.9) 28 (45.4)
Enterococcus faecalis 25 4 (160) 4 (17.4) 4 (17.4) 4 (17.4)
Streptococcus pneumoniae 11 4 (36.4) 5 (49.1) 6 (61.8) 6 (61.8)
Other 28 8 (28.6) 8 (28.6) 10 (36.8) 10 (36.8)
Negative 89 27 (30.0) 29 (33.1) 29 (33.1) 32.(37.0)
Affected valves <0.001b <0.001b <0.001b <0.001b
Aortic 113 44 (38.9) 45 (42.4) 46 (43.5) 48 (45.8)
Mitral 96 11 (11.5) 14 (15.1) 20 (21.9) 24 (26.9)
Tricuspid 18 0 (0) 0 (0) 0 (0) 0 (0)
Two native v alves 32 15 (46.9) 15 (50.5) 16 (55.5) 17 (60.4)
Prosthetic valve(s) 67 19 (28.4) 20 (30.9) 20 (30.9) 20 (30.9)
Echocardiography
Major criterion <0.001 <0.001 <0.001 0.001
Yes 221 77 (34.8) 78 (37.1) 86 (41.6) 89 (43.3)
No 105 12 (11.4) 16 (16.0) 16 (16.0) 20 (20.5)
Vegetation 0.025 0.022 0.003 0.006
Yes 198 66 (33.3) 66 (35.3) 74 (40.3) 77 (42.3)
No 128 23 (18.0) 28 (22.7) 28 (22.7) 32 (26.3)
Neurological eventsd 0.431 0.253 0.247 0.149
Yes 86 28 (32.6) 28 (35.3) 30 (38.3) 33 (43.0)
No 240 61 (25.4) 66 (28.5) 72 (31.5) 76 (33.5)
Peripheral embolid 0.079 0.038 0.072 0.073
Yes 102 36 (36.0) 36 (38.7) 37 (40.1) 39 (42.8)
No 224 53 (23.5) 58 (26.7) 65 (30.2) 70 (32.9)
Heart failured <0.001 <0.001 <0.001 <0.001
Yes 178 64 (36.0) 67 (40.7) 70 (43.1) 73 (45.6)
No 148 25 (16.9) 27(18.5) 32 (22.0) 36 (25.0)
Intravenous drug use 0.170 0.074 0.045 0.030
Yes 25 3 (12.0) 3 (12.6) 3 (12.6) 3 (12.6)
No 301 86 (28.6) 91 (31.7) 99 (35.0) 106 (39.7)
ESR on admissione 0.005 0.004 0.010 0.003
≥50 mm/h 99 18 (18.2) 19 (19.8) 22 (23.2) 23 (24.5)
< 50 mm/h 93 31 (33.3) 35 (39.6) 36 (40.8) 40 (46.0)
aMean (SD) duration of in-hospital treatment was 55 (33), range 4 to 272 days; bp values for overall group differences; ccoagulase-negative 
staphylococci; dwithin 3 months from admission; edata on erythrocyte sedimentation rate available for 192 episodesBMC Infectious Diseases 2007, 7:78 http://www.biomedcentral.com/1471-2334/7/78
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cantly associated with conditions like diabetes, collageno-
sis, malignancy, or intravenous drug use (IVDU) (all p
values > 0.065).
During the study period, mortalities were not different for
the patients who were treated surgically or conservatively
during the index hospitalisation (table 1).
Laboratory parameters (table 1)
Data on serum CRP value, ESR, WBC count, and serum
creatinine value on admission was available in 272, 192,
290, and 282 episodes of endocarditis, respectively. At all
time points, mortality was significantly higher among the
patients with CRP values ≥100 mg/l on admission than
among those with lower CRP values. The patients with
serum creatinine values ≥100 µmol/l on admission had a
significantly higher mortality at 3 months, but not later,
than the patients with normal serum creatinine values.
The ESR (≥50 mm/h) or WBC counts (≥10 × 109/l) on
admission did not associate with mortality (all p values >
0.188).
Valve surgery
Patient characteristics
Of the 109 cardiac operations performed within 1 year
after diagnosis, 43 were done within 2 weeks, 16 between
2 and 4 weeks, and 35 between 1 and 3 months. The
cumulative proportion of the patients requiring surgical
treatment is presented in table 2. The requirement for sur-
gery was at all time points significantly higher in men and
in patients < 64 years of age. The need for surgery was
unrelated to the causative microorganism. The proportion
of the episodes requiring surgical treatment was highest
for cases where 2 native valves were infected, with a signif-
icant difference between the involvement of 2 valves and
all other valve sites as a group (all p values < 0.01).
The requirement for surgery was significantly associated
with heart failure and the presence of a major criterion or
vegetation on echocardiography. The need for surgery was
not different in the patients with background conditions
such as diabetes, collagenosis, or malignancy (all p values
> 0.080). Patients with IVDU required surgery after 6
Table 3: Association between in-hospitala complications and clinical characteristics in 326 episodes of infective endocarditis
N Neurologic 
events n (%)
p value Cerebral 
emboli n (%)
p value Peripheral 
emboli n (%)
p value Heart 
failure n (%)
p value
Sex 0.404 0.297 0.354 0.538
Male 234 65 (27.8) 38 (16.2) 77 (32.9) 125 (53.4)
Female 92 21 (22.8) 10 (10.9) 25 (27.2) 53 (57.6)
Age 0.695 1.0 0.619 0.037
18–64 years 209 57 (27.3) 31 (14.8) 63 (30.1) 105 (50.2)
≥65 years 117 29 (24.8) 17 (14.5) 39 (33.3) 73 (62.4)
Etiology 0.035b 0.182b <0.001c 0.019b
Staphylococcus aureus 75 26 (34.7) 14 (18.7) 39 (52.0) 37 (49.3)
CoNSc 31 7 (22.6) 5 (16.1) 3 (9.7) 20 (64.5)
Viridans streptococci 67 18 (26.9) 15 (22.4) 20 (29.9) 28 (41.8)
Enterococcus faecalis 25 6 (24.0) 2 (8.0) 7 (28.0) 17 (68.0)
Streptococcus pneumoniae 11 7 (63.6) 2 (18.2) 3 (27.3) 10 (90.9)
Other pathogens 28 6 (21.4) 2 (7.1) 9 (32.1) 14 (50.0)
Negative 89 16 (18.0) 8 (9.0) 21 (23.6) 52.(58.4)
Affected valves 0.170b 0.105b <0.001b 0.002b
Aortic 113 30 (26.6) 16 (14.2) 43 (38.1) 64 (56.6)
Mitral 96 25 (26.0) 17 (17.7) 24 (25.0) 46 (47.9)
Tricuspid 18 3 (16.7) 0 (0) 10 (55.6) 4 (22.2)
Two native valves 32 14 (43.8) 8 (25.0) 18 (56.3) 25 (78.1)
Prosthetic valve(s) 67 19 (20.9) 7 (10.5) 7 (10.5) 39 (58.2)
Echocardiography
Major criterion 0.504 1.0 0.055 0.057
Yes 221 61 (27.6) 33 (14.9) 77 (34.8) 129 (58.4)
No 105 25 (23.8) 15 (14.3) 25 (23.8) 49 (46.7)
Vegetation 0.158 0.425 <0.001 0.088
Yes 198 58 (29.3) 32 (16.2) 76 (38.4) 116 (58.6)
No 128 28 (21.9) 16 (12.5) 26 (20.37) 62 (48.4)
Intravenous drug use 1.0 1.0 0.012 0.146
Yes 25 6 (24.0) 3 (12.0) 14 (56.0) 10 (40.0)
No 301 80 (26.6) 45 (15.0) 88 (29.2) 168 (55.8)
aMean (SD) duration of in-hospital treatment was 55 (33), range 4 to 272 days; bp values for overall group differences; ccoagulase-negative 
staphylococciBMC Infectious Diseases 2007, 7:78 http://www.biomedcentral.com/1471-2334/7/78
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months to 1 year significantly less often than those with
no IVDU.
Laboratory parameters (table 2)
There was a trend for a more common requirement for
surgery during the index hospitalisation in patients with
CRP values ≥100 mg/l on admission as compared to those
with lower CRP values, but the difference did not reach
statistical significance (p = 0.060). Patients with ESR ≥50
mm/h on admission required surgery significantly less
often than those with lower ESR values at all time points.
Elevated levels of the WBC count (≥10 × 109/l) or serum
creatinine (≥100 µmol/l) on admission were not signifi-
cantly associated with the need for surgery.
Complications during the index hospitalisation
The association between the clinical characteristics and
the development of in-hospital complications of infective
endocarditis are shown in table 3. Of the 86 patients who
had neurological complications, the complication was
manifested already on admission in 68.6% (59/86),
within 1 week from admission in 76.7% (66/86), and
within 2 weeks of admission in 86.1% (74/86) of the
patients. There were significant differences in the fre-
Table 4: Factors predicting in-hospitala mortality and mortality within 1 year from admission in 326 episodes of infective endocarditis
Hazard ratio for 
in-hospital death
95% CI p value Hazard ratio for death 
within 1 year
95% CI p value
Age 0.068 0.005
18–64 years 1 1
≥65 years 1.72 1.0–3.03 2.17 1.27–3.70
Sex 0.426 0.707
Female 1 1
Male 1.32 0.67–2.60 1.12 0.61–2.10
Etiology 0.060b 0.066b
Staphylococcus aureus 11
CoNSc 0.87 0.33–2.26 0.93 0.36–2.40
Viridans streptococci 0.90 0.40–2.03 0.85 0.40–1.81
Enterococcus faecalis 0.36 0.08–1.57 0.55 0.16–1.90
Streptococcus pneumoniae 2.37 0.85–6.59 2.58 0.94–7.09
Other pathogens 0.35 0.08–1.54 0.31 0.07–1.36
Culture negative 0.42 0.17–1.05 0.51 0.23–1.13
Affected valves <0.001b <0.001b
Prosthetic 1 1
Aortic 1.13 0.48–2.65 1.01 0.46–2.19
Mitral 0.45 0.16–1.31 0.60 0.24–1.47
Tricuspid 1.04 0.22–4.88 0.73 0.16–3.35
Two native valves 3.55 1.49–8.47 3.75 1 68–8.34
Echocardiography
Major Criterion 0.346 0.015
No 1 1
Yes 1.43 0. 68–3.00 2.44 0.19–5.0
Vegetation 0.102 0.005
No 1. 1
Yes 1.81 0.90–3.68 2.62 1.35–5.09
Neurological complicationsd 0.009 0.003
No 1 1
Yes 2.17 1.21–3.90 2.30 1.34–3.96
Peripheral embolid 0.036 0.016
No 1 1
Yes 1.86 1.04–3.33 1.95 1.14–3.35
Heart failured <0.001 <0.001
No 1 1
Yes 5.98 2.35–15.17 7.62 3.26–17.83
Serum CRP on admission 0.008 <0.001
< 100 mg/l 1 1
≥100 mg/l 2.92 1.33–6.40 3.90 1.81–8.43
aMean (SD) duration of in-hospital treatment was 55 (33), range 4 to 272 days; bp values for overall group differences; ccoagulase-negative 
staphylococci; dwithin 3 months from admissionBMC Infectious Diseases 2007, 7:78 http://www.biomedcentral.com/1471-2334/7/78
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quency of neurological complications between infective
endocarditis caused by different pathogens, these compli-
cations being most common in episodes caused by S.
pneumoniae and least common in blood culture-negative
endocarditis. Neurological complications were most com-
mon in infections of 2 native valves, and least common if
only the tricuspid valve was infected, but the differences
between infections of various valve sites were not signifi-
cant. There was no difference in the frequency of all neu-
rological complications or major cerebral emboli between
the episodes with or without a vegetation, or with or with-
out a major criterion, detected on echocardiography.
Of the 102 patients who had peripheral emboli, the com-
plication was manifested already on admission in 55.9%
(57/102), within 1 week from admission in 82.4% (84/
102), and within 2 weeks from admission in 88.2% (90/
102). Significant differences in the development of
peripheral emboli were also observed between various
causative agents and affected valve types (p < 0.001).
Table 5: Factors predicting in-hospitala surgery and surgery within 1 year from admission
Hazard ratio for in-
hospital surgery
95% CI p value Hazard ratio for surgery within 1 
year
95% CI p value
Age <0.001 <0.001
≥65 years 1 1
18–64 years 3.03 1.76 – 5.21 2.57 1.59 – 4.13
Sex 0.003 0.013
Female 1 1
Male 2.30 1.32 – 4.02 1.83 1.14 – 2.95
Etiology 0.611b 0.178b
Staphylococcus aureus 11
CoNSc 1.17 0.52 – 2.63 1.07 0.49 – 2.36
Viridans streptococci 1.55 0.81 – 2.96 1.56 0.88 – 2.77
Enterococcus faecalis 0.59 0.20 – 1.76 0.53 0.18 – 1.56
Streptococcus pneumoniae 1.59 0.53 – 4.76 2.67 1.07 – 6.65
Other pathogens 1.28 0.55 – 2.97 1.30 0.61–2.77
Culture negative 1.38 0.75 – 2.54 1.34 0.77 –2.35
Affected valve <0.001b 0.002b
Prosthetic 1 1
Aortic 1.41 0.82 – 2.42 1.47 0.87–2.48
Mitral 0.30 0.14 – 0.65 0.67 0.37–1.22
Tricuspid NAd NA NA NA
Two native valves 1.77 0.90 – 3.49 2.22 1.16–4.25
Echocardiography
Major Criterion 0.004 <0.001
No 1 1
Yes 2.99 1.63 – 5.50 2.57 1.58 – 4.18
Vegetation 0.027 0.007
No 1. 1
Yes 1.71 1.06 – 2.76 1.76 1.17 – 2.66
Neurological complicationse 0.399 0.184
No 1 1
Yes 1.22 0.77 – 1.94 1.32 0.88 – 1.99
Peripheral embolie <0.001 0.112
No 1 1
Yes 6.12 3.97 – 9.42 1.37 0.93 – 2.03
Heart failuree <0.001 <0.001
No 1 1
Yes 2.26 1.42 – 3.59 2.27 1.52 – 3.39
Serum CRP on admission
< 100 mg/l 1 1
≥100 mg/l 0.64 0.40–1.03 0.063 0.72 0.47–1.09 0.121
ESRf on admission
< 50 mm/h 1 1 0.28–0.78 0.004
≥50 mm/h 0.44 0.25–0.79 0.006 0.47
aMean (SD) duration of in-hospital treatment was 55 (33), range 4 to 272 days; bp values for overall group differences; ccoagulase-negative 
staphylococci; dNA; not applicable, 0 number of cases; ewithin 3 months from admission; ferythrocyte sedimentation rateBMC Infectious Diseases 2007, 7:78 http://www.biomedcentral.com/1471-2334/7/78
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Peripheral emboli were most common in episodes caused
by S. aureus, infections of 2 native valves and the tricuspid
valve, and least common in episodes caused by coagulase-
negative staphylococci and in PVE. The occurrence of
peripheral emboli was significantly associated with a veg-
etation detected on echocardiography, and with IVDU.
There were significant differences in the development of
heart failure between the various microorganisms as caus-
ative agents and between the infected valve sites. Heart
failure was most common in episodes caused by S. pneu-
moniae and in infection of 2 native valves, and least com-
mon in episodes caused by viridans streptococci and in
tricuspid valve endocarditis. Heart failure was signifi-
cantly associated with the age ≥65 years.
Factors predicting mortality
Patient characteristics
The factors predicting in-hospital and 1-year mortality are
presented in table 4. Age < 64 years significantly predicted
a favourable outcome within 1 year from admission but
not during the index hospitalisation. Infection of 2 native
valves significantly predicted both in-hospital and 1-year
mortality. The presence of a major criterion or vegetation
on echocardiography significantly predicted mortality
within 1 year from admission, but not during the index
hospitalisation. The occurrence of neurological complica-
tions, peripheral emboli, or heart failure significantly pre-
dicted both in-hospital and 1-year mortality.
Laboratory parameters
There was a significant trend between the level of CRP on
admission and both short-term and 1-year outcome (table
4). In the trend analysis of association, it was found that
an increment of 50 mg/l of CRP on admission was associ-
ated with a 1.33-fold hazard for in-hospital death (HR
1.33, 95% CI 1.06 to 1.68; p = 0.015) and a 1.24-fold haz-
ard for death within 1 year from admission (HR 1.24,
95% CI 1.06 to 1.46; p = 0.009). In a similar analysis, cor-
responding to every increment of 100 mg/L on admission,
the hazard for in-hospital death was 1.78-fold (HR 1.78,
95% CI 1.12 to 2.82; p = 0.015), and the hazard for 1-year
death was 1.54-fold (HR 1.54, 95% CI 1.12 to 2.12; p =
0.009). ESR level ≥50 mm/h, WBC count ≥10 × 109/l, or
serum creatinine value ≥100 µmol/l on admission did not
significantly predict in-hospital or 1-year mortality (table
4).
Among the surgically treated patients, the hazard for in-
hospital death for the patients with CRP values ≥100 mg/
l on admission was 6.85-fold as compared to those with
CRP values < 100 mg/l on admission (HR 6.85, 95% CI
1.51 to 30.95; p = 0.013). Among the conservatively
treated patients, no significant association was observed
between in-hospital mortality and the level of CRP on
admission (p = 0.181). When analysed separately for the
surgically and conservatively treated patients, no associa-
tion was observed between the level of ESR on admission
and in-hospital mortality (p values > 0.468).
Factors predicting requirement for surgery
Patient characteristics
The factors predicting the requirement for in-hospital and
1-year surgery are presented in table 5. Male sex and age <
64 years significantly predicted a need for surgery at both
of these time points, as did the development of heart fail-
ure or the presence of a major criterion or vegetation on
echocardiography. Peripheral emboli predicted a need for
in-hospital surgery, while S. pneumoniae as the causative
agent or infection of 2 native valves predicted a need for
surgery within 1 year from admission.
Laboratory parameters
Patients with CRP values ≥100 mg/l on admission tended
to require surgery during the index hospitalisation more
commonly than those with lower CRP values, but the dif-
ference was not significant (p = 0.063). In the patients
who had ESR values ≥50 mm/h on admission, the hazard
for in-hospital and 1-year surgery decreased to less than
50% as compared to those with lower ESR values (table
5).
Discussion
Previous studies have defined various clinical and labora-
tory findings, which have prognostic significance in
patients treated for infective endocarditis [5,8-12,18].
These studies have shown that the outcome of endocardi-
tis may be associated with a number of clinical variables,
e.g. age or underlying diseases of the patient, develop-
ment of complications, echocardiographic findings, labo-
ratory parameters of inflammation, and the virulence of
the causative microorganisms. However, some inconsist-
encies between the results from different hospitals are evi-
dent. At least to some extent, this may be due to
differences between the institutions or patient popula-
tions studied, or even between environmental or genetic
factors. We sought to define the prognostic significance of
some of the conventional risk predictors in patients
treated for infective endocarditis in a Finnish teaching
hospital.
Of the laboratory parameters of inflammation, the level of
CRP on admission was most prominently associated with
the outcome of endocarditis throughout the study period,
the prognosis being significantly worse in the patients
with high CRP values. Illustratively, in the patients who
had CRP values ≥100 mg/l on admission, the hazard ratio
for in-hospital death was 2.9-fold and the hazard ratio for
1-year death was 3.9-fold as compared to the patients with
lower CRP values (table 4). We are not aware of any pre-BMC Infectious Diseases 2007, 7:78 http://www.biomedcentral.com/1471-2334/7/78
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vious study focusing on the level of the first CRP value as
a prognostic sign in infective endocarditis, although Wal-
lace et al. [10] have shown that in-hospital and 6-month
mortalities were not affected by an abnormal or normal
CRP value within 48 hours of admission. Instead, these
authors found that mortality was strongly associated with
abnormal WBC counts or serum creatinine concentra-
tions. In our patients, elevated WBC counts on admission
did not predict a poor outcome, but there was a tendency
for a higher mortality in the patients with elevated serum
creatinine concentrations. This probably reflected the
worse general condition in these patients.
In many previous studies, S. aureus as the causative agent
has been associated with an adverse outcome [9,11,19-
23]. For example, in a recent study of Cabell et al. [9], S.
aureus endocarditis had a 1.5-fold increase in the risk of
death over 1 year as compared to the patients with endo-
carditis due to other pathogens. Also in the present study,
there was a tendency for a higher mortality in S. aureus
endocarditis as compared to the rest of the cases excluding
S. pneumoniae endocarditis, but the association was signif-
icant only at 3 months. In another recent study [10], S.
aureus did not confer a worse prognosis than other micro-
organisms. The authors assumed that this unconventional
finding might have been due to the fact that among their
patients with S. aureus endocarditis there was a high inci-
dence of tricuspid valve involvement in which no deaths
occurred. Consistently in our series, 20 of the 75 cases of
S. aureus endocarditis were in patients with IVDU. Of
these patients, 15 had tricuspid valve endocarditis with no
mortality. We believe that this may have contributed to
the fact that in the present study, the outcome of S. aureus
endocarditis was not significantly worse than the outcome
of endocarditis caused by other microorganisms. The high
mortality rate of 45.5% in our patients with pneumococ-
cal endocarditis is in line with previous findings [24],
demonstrating the aggressive and destructive course of
this disease.
Due to conflicting results of even the recent studies, the
relation between survival and echocardiographic findings
in infective endocarditis remains controversial. In their
comprehensive study on risk classification for mortality,
Hasbun et al. [11] found that the presence of a vegetation
was not associated with increased 6-month mortality of
endocarditis. Correspondingly, in a recent series of Chu et
al. [12] echocardiographic findings were not predictive of
in-hospital mortality. It is notable that in these two stud-
ies, the vegetation size and mobility were not analysed.
Quite the opposite, there are many other studies showing
that certain echocardiographic findings are significantly
associated with mortality. In a prospective multicentre
study, Thuny et al. [18] found that vegetation length was
a strong predictor of 1-year mortality. When studying
patients with aortic or mitral valve endocarditis, Cabell et
al. [25] showed that vegetation size was a predictor of
mortality at 30 days and 1 year. Further, in right-sided
endocarditis in drug users, size of vegetation >2 cm
proved a major prognostic factor of in-hospital mortality
[26]. In another recent series [10], a visible vegetation on
echocardiography significantly influenced 6-month mor-
tality, but not in-hospital mortality. Our results are in
good correlation with many of these findings, since at 3
and 6 months, and 1 year, mortality of the patients with a
vegetation on echocardiography was significantly higher
than mortality of the patients without a vegetation. A vis-
ible vegetation increased the hazard for death within 1
year to 2.6-fold (table 4). Regrettably, the size and mobil-
ity of vegetations were not recorded in the present study.
The role of echocardiography in predicting embolic events
has also been disputable, although recent studies suggest
that vegetations, and especially certain characteristics of
vegetations, are associated with a greater stroke rate [25].
In this respect, our results are different, since a visible veg-
etation on echocardiography significantly predicted only
peripheral emboli, not cerebral emboli or other neurolog-
ical complications.
In our patients, heart failure was the complication, which
was most significantly associated with an adverse out-
come during the index hospitalisation and up to 1 year
from admission. This corroborates other studies, which
have found heart failure to be a major risk factor for mor-
tality in endocarditis [11,27]. Also neurological complica-
tions and peripheral emboli significantly predicted both
in-hospital and 1-year mortality. These findings compare
with many previous reports [5,12]. Among the underlying
diseases, diabetes has been shown to be associated with a
higher mortality rate [12]. The results of the present study
do not corroborate this finding, as mortality in our
patients was not dependent of diabetes, or of any other
underlying conditions assessed.
Assessment of the role of cardiac surgery as a prognostic
factor is very complicated. Patients may not be operated
on because they are critically ill while some patients
undergo cardiac surgery only because they have large veg-
etations. In the present study, mortality was somewhat
higher for the surgically treated patients than for the
patients treated conservatively. This finding is evidently
due to a more severe disease with valve destructions in the
patients who underwent surgery. The severity of the dis-
ease in these surgically treated patients is illustrated e.g. by
their having a higher frequency of complications of endo-
carditis. The association between the requirement for sur-
gery and heart failure was highly significant and, in
addition, peripheral emboli were more common in
patients who needed surgical treatment, although theBMC Infectious Diseases 2007, 7:78 http://www.biomedcentral.com/1471-2334/7/78
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association was significant only at the time point of 3
months. Also, these patients had a somewhat higher fre-
quency of neurological complications than those treated
conservatively. It is of note that all of these complications
were shown to significantly predict mortality in our
patients.
Although infective endocarditis is an uncommon disease,
the long study period of 25 years made it possible for us
to include a considerable number of patients with endo-
carditis. It is of concern, however, that during such a long
period of time, there may have been changes in several
aspects of diagnostic and therapeutic management of
endocarditis. This is evidently one limitation of the
present study.
Conclusion
Some of the factors (e.g. heart failure, neurological com-
plications, peripheral emboli) predicting a poor progno-
sis and/or need for surgery in association with
endocarditis were the same as observed in previous stud-
ies, while some other previously established poor prog-
nostic factors (diabetes, elevated WBC counts) were not
present in our patient population. A new finding was that
high CRP values on admission significantly predicted
both short-term and 1-year mortality in endocarditis.
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